Postherpetic Neuralgia
📧 Sign up to get email alerts when something new happens for Postherpetic Neuralgia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Comparative Efficacy of Pregabalin and Lacosamide in Patients With Herpes Zoster and Post Herpetic Neuralgia [NA]
A clinical trial comparing pregabalin and lacosamide for herpes zoster and postherpetic neuralgia is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: High-Voltage Long-Duration Pulsed Radiofrequency Combined With Liposomal Bupivacaine Subcutaneous Block for Herpes Zoster-Associated Neuralgia [Phase 4]
Phase 4 clinical trial evaluating high-voltage long-duration pulsed radiofrequency with liposomal bupivacaine subcutaneous block for herpes …
-
CLINICAL_TRIALS research · 2025-04-27Clinical Trial Update: Esketamine Combined Pregabalin and Duloxetine for Postherpetic Neuralgia [NA]
A clinical trial is evaluating a three-drug combination of esketamine, pregabalin, and duloxetine for postherpetic neuralgia. The study is r…
-
FDA approval · 2025-04-25FDA Approved: NEURONTIN — Supplemental Application (Parke-Davis Div of Pfizer Inc)
The FDA approved a supplemental application for Neurontin (gabapentin) filed by Parke-Davis Div of Pfizer Inc, updating the product labeling…
-
FDA approval · 2025-04-25FDA Approved: GRALISE — Supplemental Application (Almatica Pharma LLC)
The FDA approved a supplemental application for Gralise (gabapentin) submitted by Almatica Pharma LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-04-25FDA Approved: HORIZANT — Supplemental Application (Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals))
The FDA approved a supplemental application for HORIZANT (gabapentin enacarbil) submitted by Azurity Pharmaceuticals. The approval updates t…
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: Esketamine Combined With PRF for Trigeminal Postherpetic Neuralgia [NA]
A clinical trial is planned to evaluate esketamine combined with pulsed radiofrequency therapy for trigeminal postherpetic neuralgia. The st…
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Esketamine Combined With PRF of DRG for Postherpetic Neuralgia [NA]
This document reports a clinical trial evaluating Esketamine combined with pulsed radiofrequency of the dorsal root ganglion for postherpeti…
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: The Treatment of Postherpetic Neuralgia in the Head and Face With Superficial Needling Combined With Electroacupuncture [NA]
A clinical trial evaluating superficial needling combined with electroacupuncture for postherpetic neuralgia in the head and face is current…
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Effectiveness of Warm Acupuncture in Patients with Postherpetic Neuralgia [NA]
The document describes a clinical trial evaluating warm acupuncture for Postherpetic neuralgia. The study status is NOT_YET_RECRUITING.
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: Subcutaneous Lidocaine Injection in Acute Herpes Zoster Neuralgia and Post-herpetic Neuralgia [NA]
This clinical trial update describes a study evaluating subcutaneous lidocaine injections for acute herpes zoster neuralgia and postherpetic…
-
FDA approval · 2025-03-13FDA Approved: GABAPENTIN — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved Granules Pharmaceuticals' supplemental application for gabapentin to add a granule formulation.
-
FDA approval · 2025-02-21FDA Approved: PREGABALIN — Original Application (Torrent Pharmaceuticals Limited)
FDA approved a generic pregabalin product from Torrent Pharmaceuticals Limited (ANDA 206942) to be used for the same indications as the refe…
-
FDA label_change · 2025-02-18FDA Approved: GABAPENTIN — Supplemental Application (American Health Packaging)
FDA approved a supplemental application for Gabapentin (generic) submitted by American Health Packaging, indicating a labeling change for th…
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: Predicting Ultrasound-Guided Thoracic PVB Success in Herpetic Neuralgia [NA]
A study from Beni-Suef University is recruiting to predict the success of ultrasound-guided thoracic paravertebral block in patients with po…
-
FDA approval · 2024-12-31FDA Approved: GABAPENTIN — Supplemental Application (ScieGen Pharmaceuticals, Inc.)
FDA approved a supplemental application for gabapentin by ScieGen Pharmaceuticals, Inc.
-
FDA label_change · 2024-12-31FDA Approved: GABAPENTIN — Supplemental Application (Laurus Labs Limited)
FDA approved a supplemental application for gabapentin filed by Laurus Labs Limited, indicating a post-approval labeling change or related u…
-
FDA approval · 2024-12-27FDA Approved: GABAPENTIN — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for gabapentin from Rising Pharma Holdings, Inc. The snippet does not specify the exact scope (e.g.,…
-
FDA approval · 2024-12-23FDA Approved: PREGABALIN — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for pregabalin filed by Chartwell RX, LLC (ANDA212865).
-
FDA approval · 2024-12-19FDA Approved: PREGABALIN — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved Ascend Laboratories' supplemental application for pregabalin (generic pregabalin).
-
FDA approval · 2024-12-12FDA Approved: PREGABALIN — Supplemental Application (Advagen Pharma Ltd.)
FDA approved the supplemental application for pregabalin from Advagen Pharma Ltd., authorizing the generic product under an ANDA.
-
FDA approval · 2024-12-10FDA Approved: GABAPENTIN — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for gabapentin from Amneal Pharmaceuticals LLC to modify an existing gabapentin product.
-
FDA approval · 2024-12-02FDA Approved: GABAPENTIN — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for gabapentin from Sun Pharmaceutical Industries, Inc., authorizing a modification to the approved …
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: Muscle Elasticity Assessment of Postherpetic Neuralgia Using Elasticity Ultrasound
This clinical trial update reports on a study evaluating muscle elasticity in postherpetic neuralgia using shear wave elastography via elast…
-
CLINICAL_TRIALS research · 2024-10-17Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Oral Administration of AJH-2947 in Healthy Korean and/or Caucasian Adult Male Subjects [Phase 1]
Phase 1 trial to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of oral AJH-2947 in healthy adult male subjects (K…